Philippe Maincent
Impact in
- Pharmaceutical Science top 0.02%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Discovery top 0.5%
Papers in
-
- Advanced Drug Delivery Systems 80
- Drug Solubulity and Delivery Systems 30
- Biomaterials 43
- Nanoparticle-Based Drug Delivery 39
- Co-authors
- Nathalie Ubrich (35 shared papers)Maurice Hoffman (33 shared papers)Alf Lamprecht (17 shared papers)Christiane Damgé (8 shared papers)Anne Sapin‐Minet (35 shared papers)Rainer Helmut Müller (3 shared papers)Francine Kedzierewicz (11 shared papers)Roland A. Bodmeier (8 shared papers)
In The Last Decade
Philippe Maincent
143 papers receiving 6k citations
Peers
Comparison fields: 5 of 123
- Pharmaceutical Science 3.6k
- Drug Discovery 51
- Biomaterials 2.1k
- Molecular Medicine 346
- Food Science 310
Countries citing papers authored by Philippe Maincent
This map shows the geographic impact of Philippe Maincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Maincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Maincent more than expected).
Fields of papers citing papers by Philippe Maincent
This network shows the impact of papers produced by Philippe Maincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Maincent. The network helps show where Philippe Maincent may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Maincent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 350 | |
| 2 | 2001 | 335 | |
| 3 | 2006 | 302 | |
| 4 | 2001 | 225 | |
| 5 | 2013 | 223 | |
| 6 | 1996 | 193 | |
| 7 | 2002 | 180 | |
| 8 | 2000 | 164 | |
| 9 | 2000 | 157 | |
| 10 | 2007 | 156 | |
| 11 | 1998 | 150 | |
| 12 | 1999 | 140 | |
| 13 | 1986 | 119 | |
| 14 | 2007 | 118 | |
| 15 | 2000 | 116 | |
| 16 | 2006 | 112 | |
| 17 | 2004 | 110 | |
| 18 | 1993 | 95 | |
| 19 | 2018 | 95 | |
| 20 | 2015 | 91 |
About Philippe Maincent
Philippe Maincent is a scholar working on Pharmaceutical Science, Biomaterials, Analytical Chemistry, Hematology and Biochemistry, having authored 143 papers that have together received 6.4k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (80 papers), Nanoparticle-Based Drug Delivery (39 papers), Drug Solubulity and Delivery Systems (30 papers), Analytical Methods in Pharmaceuticals (9 papers), Iron Metabolism and Disorders (5 papers), Sulfur Compounds in Biology (4 papers), Electrostatics and Colloid Interactions (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (4 papers). The work is most often cited by research in Pharmaceutical Science (3.6k citations), Drug Discovery (51 citations), Biomaterials (2.1k citations), Molecular Medicine (346 citations) and Food Science (310 citations). Philippe Maincent has collaborated with scholars based in France, Germany and China. Frequent co-authors include Nathalie Ubrich, Maurice Hoffman, Alf Lamprecht, Christiane Damgé, Anne Sapin‐Minet, Rainer Helmut Müller, Francine Kedzierewicz, Roland A. Bodmeier, Claus‐Michael Lehr and C. Vigneron. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Journal of Pharmaceutical Sciences, Pharmaceutical Research and Journal of Microencapsulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.